Makar A - Search Results

1

[Surgery and sentinel node examination in early vulvar cancer].

Tropé C, Scheistrøen M, Aas M, Abeler V, Lie K, Makar A. Tropé C, et al. Among authors: makar a. Tidsskr Nor Laegeforen. 2001 Sep 30;121(23):2723-7. Tidsskr Nor Laegeforen. 2001. PMID: 11699381 Review. Norwegian.

2

[Controversies in surgical treatment of advanced ovarian cancer].

Tropé C, Paulsen T, Baekelandt M, Makar A. Tropé C, et al. Among authors: makar a. Tidsskr Nor Laegeforen. 2000 Mar 10;120(7):824-30. Tidsskr Nor Laegeforen. 2000. PMID: 10806907 Review. Norwegian.

3

[Fertility preservation in gynecologic cancer].

Tropé C, Scheistrøen M, Makar AP. Tropé C, et al. Among authors: makar ap. Tidsskr Nor Laegeforen. 2001 Apr 20;121(10):1234-9. Tidsskr Nor Laegeforen. 2001. PMID: 11402751 Review. Norwegian.

4

Surgical management of stage I and II vulvar cancer: the role of the sentinel node biopsy. Review of literature.

Makar AP, Scheistroen M, van den Weyngaert D, Tropé CG. Makar AP, et al. Int J Gynecol Cancer. 2001 Jul-Aug;11(4):255-62. doi: 10.1046/j.1525-1438.2001.011004255.x. Int J Gynecol Cancer. 2001. PMID: 11520362 Review.

5

Gynecologic malignancy and surgery: from quantity to quality of life.

Makar AP, Tropé CG. Makar AP, et al. Curr Opin Obstet Gynecol. 1992 Jun;4(3):419-29. Curr Opin Obstet Gynecol. 1992. PMID: 1623153 Review.

6

Surgery for borderline tumor of the ovary.

Tropé CG, Kristensen G, Makar A. Tropé CG, et al. Among authors: makar a. Semin Surg Oncol. 2000 Jul-Aug;19(1):69-75. doi: 10.1002/1098-2388(200007/08)19:1<69::aid-ssu11>3.0.co;2-e. Semin Surg Oncol. 2000. PMID: 10883027 Review.

7

Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: new aspects and multivariate analysis.

Makar AP, Kristensen GB, Kaern J, Børmer OP, Abeler VM, Tropé CG. Makar AP, et al. Obstet Gynecol. 1992 Jun;79(6):1002-10. Obstet Gynecol. 1992. PMID: 1579296

8

The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer.

Makar AP, Baekelandt M, Tropé CG, Kristensen GB. Makar AP, et al. Gynecol Oncol. 1995 Feb;56(2):175-80. doi: 10.1006/gyno.1995.1027. Gynecol Oncol. 1995. PMID: 7896181

9

Unsettled questions regarding ovarian cancer.

Tropé C, Makar A. Tropé C, et al. Among authors: makar a. Acta Obstet Gynecol Scand Suppl. 1992;155:7-18. doi: 10.1111/j.1600-0412.1992.tb00002.x. Acta Obstet Gynecol Scand Suppl. 1992. PMID: 1502893 Review. No abstract available.

10

DNA flow cytometry as a new prognostic factor in ovarian malignancies. A review.

Tropé C, Makar A, Kaern J. Tropé C, et al. Among authors: makar a. Acta Obstet Gynecol Scand Suppl. 1992;155:95-7. doi: 10.1111/j.1600-0412.1992.tb00013.x. Acta Obstet Gynecol Scand Suppl. 1992. PMID: 1502897 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page